Osteocalcin Polyclonal antibody
Osteocalcin Polyclonal Antibody for FC, IF, IHC, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
IHC, IF, FC, ELISA
Conjugate
Unconjugated
Cat no : 16157-1-AP
Synonyms
Validation Data Gallery
Tested Applications
Positive IHC detected in | human osteosarcoma tissue, mouse lung tissue, rat lung tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF detected in | NIH/3T3 cells |
Positive FC detected in | U2OS cells |
Recommended dilution
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF) | IF : 1:50-1:500 |
Sample-dependent, check data in validation data gallery |
Published Applications
IHC | See 1 publications below |
IF | See 1 publications below |
Product Information
16157-1-AP targets Osteocalcin in IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Cited Reactivity | mouse |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | Peptide |
Full Name | bone gamma-carboxyglutamate (gla) protein |
Calculated molecular weight | 11 kDa |
GenBank accession number | NM_199173 |
Gene symbol | BGLAP |
Gene ID (NCBI) | 632 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
Product Specific Protocols | |
---|---|
IHC protocol for Osteocalcin antibody 16157-1-AP | Download protocol |
IF protocol for Osteocalcin antibody 16157-1-AP | Download protocol |
FC protocol for Osteocalcin antibody 16157-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Aging (Albany NY) Primary cilia regulate gastric cancer-induced bone loss via cilia/Wnt/β-catenin signaling pathway. | ||
Front Pharmacol Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization. |